Tickerplace logo

Tickerplace

MapLight Therapeutics, Inc. logo

MPLTMapLight Therapeutics, Inc.

MPLT Stock Price, Valuation & Chart | MapLight Therapeutics, Inc.

Compare
$13.060-0.25 (-1.88%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyMPLT intrinsic valueMPLT calculated fair value vs price
OverviewFinancialsDividendsRatios

MPLT Historical price chart

MPLT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization554.22M
PE Ratio-0.34
EPS-38.52
Trading Volume937.65K
Today's High/Low13.94/12.82
Dividend Yield0.00
52 Week High/Low40.43/9.1
Shares Outstanding42.44M
MPLT Financial Statement
MPLT Analyst ratings
MPLT Analysis & performance metrics

MPLT Company profile

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's…

MPLT Management team

MPLT Frequently asked questions

What is MapLight Therapeutics, Inc. (MPLT) Stock Price?

Current stock price of MapLight Therapeutics, Inc. (MPLT) stock is $13.060. The stock price is -1.88% lower in the session. The intraday range can be seen from this page. Volume of MapLight Therapeutics, Inc. (MPLT) stock is 937.65K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the MapLight Therapeutics, Inc. (MPLT) stock price going up or down today?

The stock price of MapLight Therapeutics, Inc. (MPLT) can change with earnings, company news, and overall market sentiment. MapLight Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the MapLight Therapeutics, Inc. stock expensive at its current price?

Whether MapLight Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MPLT on this page is -0.34. EPS on this page is -38.52. Compare those figures with peers and growth expectations before deciding if the current MapLight Therapeutics, Inc. price is justified.

How has the stock price of MapLight Therapeutics, Inc. (MPLT) performed historically?

Historical performance for MapLight Therapeutics, Inc. (MPLT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MPLT reacted to past earnings and market events.

Should I buy MapLight Therapeutics, Inc. (MPLT) stock, at this price?

Buying MapLight Therapeutics, Inc. (MPLT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.